Publications by authors named "Valeria Pechtner"

Claim this Profile
G
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?
Raffaella Gentilella, Valeria Pechtner, Antonella Corcos, Agostino Consoli

Diabetes Metab Res Rev· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement.
Francesco Giorgino, Alfred Penfornis, Valeria Pechtner, Raffaella Gentilella, Antonella Corcos

Patient Prefer Adherence· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2).
Francesco Giorgino, Marian Benroubi, Jui-Hung Sun, Alan G Zimmermann, Valeria Pechtner

Diabetes Care· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes in a randomized controlled trial (AWARD-3).
Guillermo Umpierrez, Santiago Tofé Povedano, Federico Pérez Manghi, Linda Shurzinske, Valeria Pechtner

Diabetes Care· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study.
Morvarid Kabir, Geraldine Skurnik, Nadia Naour, Valeria Pechtner, Emmanuelle Meugnier

Am J Clin Nutr· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis